Clinical Trials Browser

Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Cardiofaciocutaneous syndrome, Legius syndrome, Neurofibromatosis 1, Noonan Syndrome, Genetic Diseases, Inborn, Costello Syndrome

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1

Neurofibromatosis 1

Dyslexia, Learning Disabilities, Neurofibromatosis 1

Neurofibromatosis 1, Chronic Pain

Hypertension, Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Social Skills

Neurofibromatosis 1, Social Skills

Autism Spectrum Disorder, Inhibition, Psychological, Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Neurofibromatosis 2

Neurofibromatosis 1, Muscle Weakness

Neurofibromatosis, type 4, of Riccardi, Neurofibroma, Neurofibromatosis 1, Neurofibroma, Plexiform

Brain Neoplasms, Glioma, Neoplasms, Neurofibromatosis 1

Constipation, Neurofibromatosis 1, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1

Schwannomatosis, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

Dyslexia, Neurofibromatosis 1

Dyslexia, Neurofibromatosis 1

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Clinical Trials

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

iCanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis

Neurobiology and Treatment of Reading Disability in NF-1

Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

OPTIMAL-SSI

COGTRAIN

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

Open Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Pilot Randomized Control Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

ASD/NF1inhib

Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Whole-body Vibration in Children With Neurofibromatosis Type 1

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Feasibility and Clinically Application of Magnetic Resonance Fingerprinting

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children

NF1-QDV

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Functional Imaging and Reading Deficit in Children With NF1

Reading Disability in Children With NF1

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma